Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
27
pubmed:dateCreated
2011-7-6
pubmed:abstractText
Nitrogen bisphosphonates (NBPs) are commonly prescribed for osteoporosis but have also been found to induce inflammatory reactions and to delay the progression of breast cancer. The inflammatory and anticancer effects of the NBPs might be associated with an ability to modulate innate immune signaling. In mice, intraperitoneal NBP administration causes a rapid influx of neutrophils and monocytes that is dependent on the myeloid differentiation primary response gene 88 (MyD88) mediator of Toll-like receptor (TLR) and IL-1 signaling. Bone marrow chimeras demonstrate that this inflammatory response is partially dependent on TLR4 expression by hematopoietic cells and the IL-1 receptor on radioresistant cells. In vitro, NBPs directly stimulate neither murine bone marrow-derived mononuclear cells nor human peripheral blood mononuclear cells, but rather prime them to produce increased amounts of cytokines when exposed to IL-1 or TLR ligands. This potentiation is mediated by a reduction in IL-1 receptor-associated kinase-M, a negative regulator of MyD88-dependent signaling. In vivo, this property renders the NBPs as effective adjuvants that enhance both cellular and antibody responses to antigens.
pubmed:grant
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Jul
pubmed:issn
1091-6490
pubmed:author
pubmed:issnType
Electronic
pubmed:day
5
pubmed:volume
108
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
11163-8
pubmed:meshHeading
pubmed-meshheading:21690387-Adaptive Immunity, pubmed-meshheading:21690387-Adjuvants, Immunologic, pubmed-meshheading:21690387-Animals, pubmed-meshheading:21690387-Bone Marrow Cells, pubmed-meshheading:21690387-Diphosphonates, pubmed-meshheading:21690387-Humans, pubmed-meshheading:21690387-Immunity, Cellular, pubmed-meshheading:21690387-Inflammation, pubmed-meshheading:21690387-Interleukin-1 Receptor-Associated Kinases, pubmed-meshheading:21690387-Mice, pubmed-meshheading:21690387-Mice, Inbred C3H, pubmed-meshheading:21690387-Mice, Inbred C57BL, pubmed-meshheading:21690387-Mice, Knockout, pubmed-meshheading:21690387-Myeloid Differentiation Factor 88, pubmed-meshheading:21690387-Peritonitis, pubmed-meshheading:21690387-Receptors, Interleukin-1, pubmed-meshheading:21690387-Signal Transduction, pubmed-meshheading:21690387-Toll-Like Receptor 4
pubmed:year
2011
pubmed:articleTitle
Role of IL-1 receptor-associated kinase-M (IRAK-M) in priming of immune and inflammatory responses by nitrogen bisphosphonates.
pubmed:affiliation
Moores Cancer Center and Department of Medicine, University of California at San Diego, La Jolla, CA 92093, USA.
pubmed:publicationType
Journal Article, Research Support, N.I.H., Extramural